Adhera Therapeutics Inc (ATRX)

[mrinvestor08]

Scoop 1 product gone in December from debt elimination deal...now last one gone too tied to melior...wondering if they still have this product mentioned on their otc profile?

In addition to advancing both drug candidates in Phase 2 clinical trials, the Company remains active in exploring other advanced drug development opportunities while maintaining its legacy assets, including CEQ508, an oral delivery of small interfering RNA (siRNA) against beta-catenin, to suppress polyps in the precancerous syndrome and orphan indication Familial Adenomatous Polyposis (FAP).